Cost Management

Cost management in VBC is shifting from broad total-cost accountability toward more targeted specialty and utilization-management models, with kidney, GI, joint replacement, and home-based care programs exposing the operational burden of scaling savings beyond pilots. Recent case studies around Blue Cross NC’s Advanced Kidney Care program and Oshi Health’s GI model show payers leaning into risk-aligned specialty partnerships to reduce avoidable spend, while commentary on Independence at Home and CJR-X underscores that data infrastructure, patient selection, and care-team capacity remain limiting factors for replication.

At the same time, Medicare Advantage and CMS-led utilization controls are becoming a sharper policy flashpoint: more than half of eligible Medicare beneficiaries are now in MA, but OIG scrutiny of high prior-authorization denial rates and Senate Democratic efforts to unwind CMS’s WISeR AI prior authorization model signal rising resistance to savings strategies perceived as restricting access. For ACOs, health systems, and payers, the strategic challenge is to prove that cost management tools—whether specialty bundles, risk-based contracts, or AI-enabled review—produce measurable affordability gains without triggering access, equity, or regulatory backlash (AKC case study; WISeR rollback effort).